A detailed history of Titleist Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Titleist Asset Management, LLC holds 467 shares of LLY stock, worth $365,740. This represents 0.06% of its overall portfolio holdings.

Number of Shares
467
Previous 467 -0.0%
Holding current value
$365,740
Previous $423 Million 2.12%
% of portfolio
0.06%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$724.87 - $909.04 $64,513 - $80,904
89 Added 23.54%
467 $423 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $223,851 - $299,481
378 New
378 $294 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Titleist Asset Management, LLC Portfolio

Follow Titleist Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Titleist Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Titleist Asset Management, LLC with notifications on news.